Regional infrastructure tied to inappropriate breast, prostate cancer imaging
the ONA take:
Danil Makarov, MD, MHS, of the New York University School of Medicine and fellow researchers user SEER-Medicare data to identify patients with low-risk prostate or breast cancer.
While these two cancers affect different patient populations and therefore should not share an association in imaging, the researchers found a correlation between regional rates, leading them to believe that regional behaviors share common determinants.
They identified 9,2119 men with prostate cancer and 30,398 women with breast cancer in 84 hospital referral regions, with rates of inappropriate imaging found to be 44.4 percent and 41.8 percent, respectively.
Inappropriate prostate cancer imaging rates were associated with those of breast cancer rates at the hospital referral region level. This meant that a man with low-risk prostate cancer had a higher chance of undergoing inappropriate imaging if he lived in a hospital referral region with higher inappropriate breast cancer imaging levels.
“Our findings suggest that practice patterns may be a function of local propensities for health care utilization,” the authors stated. “This is a novel finding with great relevance to cancer policy.”
Regional infrastructure could contribute to inappropriate imaging in patients at risk for prostate and breast cancer.
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- G-CSF May Help Preserve Fertility in Male Patients With Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Patients With HER2-enriched Subtype Benefit Most from Dual HER2 Blockade
- Scalp Cooling Reduces Risk of Chemotherapy-Induced Alopecia
- CRISPR Illustrates Progression of Normal Blood Cells to Leukemia, Precursor Diseases
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|